降糖药
- 网络hypoglycemics;hypoglycemic agent;Antidiabetic Agents
-
钠-葡萄糖共转运体抑制剂(sodium-glucoseco-transporter,SGLT-2抑制剂)是目前开发的一种新的、有效的降糖药方向之一。
Sodium-glucose co-transporter is currently developing a new , efficient one of hypoglycemic agents .
-
二肽基肽酶Ⅳ抑制剂(?)(dipeptidylpeptidase-4inhibitor,DPP-Ⅳ抑制剂)就是目前开发的一种新的、有效的降糖药之一。
Dipeptidyl peptidase ⅳ inhibitor ( dipeptidyl peptidase-4 inhibitor , DPP - ⅳ inhibitors ) is currently developing a new , efficient one of hypoglycemic agents .
-
诺和灵N联合口服降糖药治疗老年糖尿病的临床观察
Clinical observation of recombinant human insulin injection novolin N and oral hypoglycemia agent combination therapy on elderly diabetes mellitus
-
结论用重组人胰岛素诺和灵N联合口服降糖药治疗老年糖尿病是安全有效的。
[ Conclusion ] Recombinant human insulin injection Novolin N and oral hypoglycemia agent combination therapy on elderly diabetes mellitus is safety and effective .
-
方法31例符合WHO诊断标准口服降糖药治疗血糖控制不满意的老年糖尿病患者,联合睡前注射诺和灵N。
[ Methods ] Included were 31 cases of elderly diabetes mellitus diagnosed by criteria of WHO . All patients had lower effect on oral hypoglycemia agent , were added to given Novolin N injection at bedtime .
-
盐酸二甲双胍(metforminhydrochloride,简称MH)是双胍类降糖药,是目前临床应用最为广泛的降血糖药物之一。
Metformin Hydrochloride ( MH ) is a drug of the biguanides class , which is one of the most useful blood-glucose-lowering drug in clinical .
-
⑵老年DM住院患者随病程延长口服降糖药治疗者明显减少,胰岛素应用比例逐渐增加,但总体胰岛素使用率较低;
⑵ With the increase of course , inpatients respectively with therapy of OHA or insulin significantly decreased and increased , but the overall ratio of insulin was low .
-
方法:80例患者随机分为针刺治疗组(A)、运动疗法组(B)、针刺结合运动疗法组(C)、和单纯进行合理饮食及口服降糖药治疗对照组(D)。
Methods 80 cases were randomly divided into acupuncture treatment group ( A ), exercise therapy group ( B ), acupuncture plus exercise therapy group ( C ), and control group ( D ) treated with rational diet and oral administration of hypoglycemia agents .
-
结果:2001~2003年我院口服降糖药的DDDs呈现逐年上升,其中格列齐特、甲苯磺丁脲、二甲双胍位居前列;
Result : The DDDs of oral antidiabetic agents rised gradually from 2001 to 2003.The front of DDDs were among Gliclazide , Tolbutamide and Metformin .
-
结论初诊的T2DM患者可能较口服降糖药效果差的T2DM患者对胰岛素泵降糖效果更满意。
Conclusions The effect of treating hyperglycemia on insulin pump therapy in newly diagnosed T2DM is better than that in T2DM with failure to oral antidiabetic therapy .
-
此结果为POV降低高血糖的分子生化机理提供理论依据,亦为探讨治疗糖尿病新的降糖药提供实验基础。
The results provided theoretic basis for the molecular biochemical mechanism of POV lowering hyperglycemia , and provided experimental base for exploring a new lowering hyperglycemia drug .
-
方法对我院2000年~2003年口服降糖药的用药金额、用药频度(DDDs)及每日药费进行统计分析。
Methods To make a statistic analysis of the Oral Hypoglycemic agents used in my hospital during the period 2000 ~ 2003 with the sum of money , DDDs and daily cost .
-
34例NIDDM患者经饮食控制和/或口服降糖药治疗4个月后进行了复查,结果显示:12例代谢改善者的GFR、肾脏体积和UAE有不同程度的恢复;
Thirty-four NIDDM patients were given 4-month dietary control and / or oral hypoglycemic agent treatment and it showed that the GFR , kidney volume and UAE were partially reduced in 12 patients with improved metabolic control ;
-
LBP-D与降糖药对糖尿病小鼠模型血糖和细胞免疫功能的影响
The Effects of LBP-D and Hypoglycemic Agents on Blood Glucose and the Function of Cellular Immunity in Alloxan-induced Diabetes Mice
-
结论口服降糖药治疗且血糖控制不良的2型糖尿病患者,睡前加用基础胰岛素,可使绝大多数患者血糖获得理想控制(HbAlc≤7%)。
Conclusion Bedtime basal insulin added to oral therapy can safely achieve HbAlc less than 7 % in majority of patients with type 2 diabetes with HbAlc > 7.5 % on oral agents alone .
-
目的探讨每日2次注射预混门冬胰岛素30(诺和锐30特充)和预混人胰岛素30R(诺和灵30R)治疗口服降糖药效果不佳的2型糖尿病的疗效及低血糖风险。
Objective To compare the efficacy and safety of premixed insulin aspart with human insulin premix used in a twice-daily injection in the patients with type 2 diabetes .
-
结果2004年与2001年相比,两院Ⅱ型糖尿病住院人数增长了88.28%;与此同时,DDDs增长了5311.49%,而口服降糖药的年用药金额却增长了71.63倍;
Results In 2004 while the inpatients of diabetes was increased by 64.86 % , the sum of money was increased 71.63 times , and DDDs was increased by 5311.49 % in comparison with that in 2001 . Among them , Repaglinide increased very quickly oral hypoglycemic drug .
-
方法40例用口服降糖药血糖控制不良的2型糖尿病患者随机分为甘精胰岛素组(简称甘精组)和预混胰岛素组(诺和灵30R,简称预混组),每组各20例。
Methods Forty type 2 diabetes patients which could not control the blood glucose successfully with drugs were divided into two groups randomly : glargine group ( 20 cases ) and mixed insulin group ( 20 cases ) .
-
这两种降糖药具有受体作用的专一性,用药安全,耐受性良好,抗高血压作用显著,副作用小的特点。5-羧酸洛沙坦(EXP-3174)是洛沙坦的活性代谢产物。
The two antihypertensive drugs are characteristics of specific receptor , medication safety , well-tolerated , significant antihypertensive effect , lower side effect.5-carboxylic acid Losartan ( EXP-3174 ) is the active metabolite of Losartan .
-
利用四氧嘧啶静脉注射(100mg/kg)诱导的糖尿病小鼠模型,观察LBP-D单独及与降糖药联合应用对小鼠血糖和细胞免疫功能的影响。
An experimental diabetic model was induced by vein injection of alloxan monohydrate ( 100 mg / kg ) . We observed the effects of LBP-D , hypoglycemic agents alone or in combination , on blood glucose and the functions of cellular immunity in alloxan-induced diabetes mice .
-
其他许多降糖药也有类似情况。
This is true of many other diabetes pills , too .
-
我院口服降糖药的药物利用分析
Analysis of Drug Utilization of Oral Antidiabetic Agents in Our Hospital
-
我院口服降糖药使用现状调查与分析
Survey the actuality of using oral hypoglycemic drug in our hospital
-
2型糖尿病患者口服降糖药的成本效果分析
Cost-effectiveness analysis of drugs in treatment of type 2 diabetes mellitus
-
双胍类降糖药治疗糖尿病血乳酸水平的观察
Alteration of blood lactic acid level on biguanides therapy in diabetics
-
本院老年糖尿病患者口服降糖药分析
Analysis of Use of Oral Antidiabetic Drugs in Elderly Diabetic Patients
-
胰岛素和口服降糖药合用治疗Ⅱ型糖尿病
Combination therapy with insulin and oral hypoglycemic agent for type ⅱ diabetes
-
我院2006&2008年降糖药回顾性动态分析
The Retrospectively Dynamic Analysis of Hypoglycemic Agents in 2006-2008 at Our Hospital
-
试验前,每个患者均服用了二甲双胍和一种磺酰脲类降糖药。
At baseline , each patient was taking metformin and a sulfonylurea .
-
我院2004&2007年降糖药利用分析
Analysis of Hypoglycemic Drugs Used in Our Hospital from 2004 to 2007